Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma-Is This the New Standard of Care? | JAMA Oncol;8(5): 715-716, 2022 05 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma-Is This the New Standard of Care?

Willis, Maurice.

Affiliation

Willis M; University of Texas Medical Branch, Galveston.

JAMA Oncol ; 8(5): 715-716, 2022 05 01.

Article in En | MEDLINE | ID: mdl-35323867

Subject(s)

Induction Chemotherapy; Nasopharyngeal Neoplasms; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Chemoradiotherapy; Cisplatin/therapeutic use; Humans; Nasopharyngeal Carcinoma/drug therapy; Nasopharyngeal Neoplasms/drug therapy; Standard of Care

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Induction Chemotherapy Limits: Humans Language: En Journal: JAMA Oncol Year: 2022 Document type: Article Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / Induction Chemotherapy Limits: Humans Language: En Journal: JAMA Oncol Year: 2022 Document type: Article Country of publication: United States